CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $1.4M of Corcept Therapeutics Incorporated
Sold$1,412,000
$70.60Price
20,000Shares
−83%Stake
What CORT did after the filing
- The stock from Fri, Jun 5 open, $74.77
- +27.9%
- S&P 500, same days
- −0.5%
Measured over 30 trading days, to the Jul 21 close.
Traded Tue, Jun 2. Filed Thu, Jun 4, 4:49 PM ET, after the close. Returns use the Jun 5 open and the Jul 21 close. Not investment advice.